Share chart Gland Pharma Limited
About Gland Pharma Limited
Gland Pharma Limited, компания, специализирующаяся на инъекционных препаратах-дженериках, занимается разработкой, производством, продажей и распространением фармацевтических препаратов. Основные молекулы компании включают гепарин натрия, эноксапарин натрия, бромид рокурония и инъекции даптомицина, а также другие. more details| ISIN | INE068V01023 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Валюта отчета | inr |
| Див.доход ао | 1.07 |
| Дивиденд ао | 20 |
| Сайт | https://www.glandpharma.com |
| Цена ао | 1623.1 |
| Change price per day: | -1.12% (1623.1) |
|---|---|
| Change price per week: | +0.8293% (1591.65) |
| Change price per month: | +0.4349% (1597.9) |
| Change price per 3 month: | -12.03% (1824.35) |
| Change price per half year: | -10.04% (1784.05) |
| Change price per year: | -13.03% (1845.25) |
| Change price per 3 year: | -50.53% (3244.2) |
| Change price per year to date: | -9.72% (1777.6) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares MSCI India Small-Cap ETF | 0.19314 | -11.12 | 0.96163 |
WisdomTree India Earnings Fund
|
0.05762 | -6.18 | 1.65591 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.05118 | 7.67 | 2.7853 |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.00753 | 12.46 | 3.59676 |
| Avantis Emerging Markets Equity ETF | 0.00404 | -7.58 | 3.60513 |
| SPDR Portfolio Emerging Markets ETF | 0.00397 | -2.03 | 3.1879 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.00189 | 15.96 | 3.34087 |
| Dimensional Emerging Markets Value ETF | 0.00035 | 17.07 | 4.19508 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0 | 9.39 | 3.09932 |
| 0.03 | 3.96 | 2.94 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Srinivas Sadu | CEO & Executive Chairman | 123.58M | 1969 (56 years) |
| Mr. Ravi Shekhar Mitra | Chief Financial Officer | 15.15M | 1977 (48 years) |
| Mr. Sampath Kumar Pallerlamudi | Company Secretary & Vice-President of Compliance & CSR | 5.11M | 1981 (44 years) |
| Mr. Ankit Gupta | Head of Investments, Strategy & Investor Relations | N/A | |
| Mr. Satnam Singh Loomba | Chief Operating Officer | 1968 (57 years) | |
| Mr. Surinder Koul | Head of Domestic Marketing | ||
| Dr. Surapanini Sridevi | Senior Vice President of R&D | 1968 (57 years) | |
| Mr. K Raghuramachandra Rao | Head of Quality | ||
| Mr. Rong Wu | Chief Financial Controller |
Address: India, Hyderabad, Plot No. 11 & 84 TSIIC Phase: IV - open in Google maps, open in Yandex maps
Website: https://www.glandpharma.com
Website: https://www.glandpharma.com
